CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 187 filers reported holding CRISPR THERAPEUTICS AG in Q3 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,026,865 | +17.9% | 88,717 | +45.8% | 0.16% | +23.0% |
Q2 2023 | $3,415,670 | +227.2% | 60,842 | +136.9% | 0.13% | +180.0% |
Q4 2022 | $1,043,973 | -72.6% | 25,682 | -56.0% | 0.04% | -75.3% |
Q3 2022 | $3,815,000 | -28.0% | 58,382 | -33.0% | 0.18% | -23.8% |
Q2 2022 | $5,296,000 | -2.1% | 87,152 | +1.1% | 0.24% | +21.3% |
Q1 2022 | $5,408,000 | -39.7% | 86,163 | -27.2% | 0.20% | -33.4% |
Q4 2021 | $8,969,000 | -32.6% | 118,352 | -0.5% | 0.30% | -40.9% |
Q3 2021 | $13,311,000 | -29.8% | 118,927 | +1.5% | 0.50% | -30.0% |
Q2 2021 | $18,969,000 | +42.2% | 117,172 | +7.0% | 0.72% | +28.1% |
Q1 2021 | $13,340,000 | -7.5% | 109,481 | +16.2% | 0.56% | -13.7% |
Q4 2020 | $14,422,000 | +93.2% | 94,192 | +5.5% | 0.65% | +69.6% |
Q3 2020 | $7,466,000 | +10.8% | 89,265 | -2.7% | 0.38% | -1.5% |
Q2 2020 | $6,741,000 | +139.9% | 91,720 | +38.4% | 0.39% | +99.0% |
Q1 2020 | $2,810,000 | +22.7% | 66,260 | +76.2% | 0.20% | +47.7% |
Q4 2019 | $2,291,000 | +122.0% | 37,610 | +49.4% | 0.13% | +100.0% |
Q3 2019 | $1,032,000 | -3.0% | 25,170 | +11.4% | 0.07% | -4.3% |
Q2 2019 | $1,064,000 | – | 22,600 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |